Additionally, we questioned the kinetics of the PSMA PET signal in the prostate throughout this late dynamic acquisition in order to evaluate the adequacy of the PSMA PET protocol for the purposes of biopsy planning, primary staging and chemical recurrence detection in prostate cancer. The gene discussed is FOLH1; the disease is Familial prostate cancer.